Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number Sort ascending | Exp. Date | Activity Code(s) | Title |
|---|---|---|---|
| PAR-24-043 | August 19, 2026 | UG3/UH3 | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
| PAR-23-318 | March 21, 2026 | R21/R33 | Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) |
| PAR-23-309 | November 6, 2026 | R01 | Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional) |
| PAR-23-299 | January 8, 2027 | R21 | Intervention Research to Improve Native American Health (R21 Clinical Trials Optional) |
| PAR-23-298 | January 8, 2027 | R01 | Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) |
| PAR-23-297 | September 8, 2026 | R01 | Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed) |
| PAR-23-296 | September 8, 2026 | R21 | Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed) |
| PAR-23-295 | November 17, 2026 | R03 | Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) |
| PAR-23-294 | November 19, 2026 | R21 | Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) |
| PAR-23-293 | November 19, 2026 | R01 | Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) |
| PAR-23-285 | January 8, 2027 | R34 | Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) |
| PAR-23-222 | May 8, 2027 | F99/K00 | Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed) |
| PAR-23-199 | May 26, 2025 | U24 | ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed) |
| PAR-23-193 | April 4, 2026 | X01 | Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed) |
| PAR-23-192 | May 3, 2025 | X01 | Biological Testing Facility (X01 Clinical Trial Not Allowed) |
| PAR-23-180 | December 8, 2024 | R01 | Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) |
| PAR-23-171 | May 16, 2025 | X01 | Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) |
| PAR-23-166 | August 8, 2026 | S06 | Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) |
| PAR-23-160 | October 18, 2024 | R03 | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) |
| PAR-23-159 | October 18, 2024 | R21 | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) |
BACK TO TOP